Compare Amphastar Pharmaceuticals Inc (AMPH) vs Plug Power Inc (PLUG) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

PLUG trades at $2.23, down 6.3% on the day, with a bearish technical signal and negative cash flows. The company reported a net loss of $1.63 billion in 2025 despite revenue of $710 million, with gross profit margin at -25.66%. Recent news includes a 50MW electrolyzer order for the Hunter Valley Hydrogen Hub in Australia, but the stock faces pressure from analyst target cuts and high short interest of 27.4%.

Outlook remains challenged by persistent losses and cash burn, though analyst consensus suggests 31% upside to the $2.92 target. Key risks include delayed profitability targets beyond 2028 and reliance on financing amid negative operating cash flow. The stock's viability hinges on successful project execution and hydrogen market adoption.